Top-News

CALLIDITAS THERAP. AD 1/2 News

Aktie
WKN:  A2P57K ISIN:  US13124Q1067 US-Symbol:  CALT
18,80 €
-0,10 €
-0,53%
03.05.24 21:43:48
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

CALLIDITAS THERAP. AD 1/2 News

24.04.24 - PR Newswire
Calliditas Therapeutics' 2023 Annual Report Published
Calliditas Therapeutics' 2023 Annual Report Published PR Newswire
24.04.24 - PR Newswire
Calliditas Therapeutics' 2023 Annual Report Published
Calliditas Therapeutics' 2023 Annual Report Published PR Newswire
24.04.24 - PR Newswire
Calliditas Announces Positive NefIgArd Open Label Extension Results
Calliditas Announces Positive NefIgArd Open Label Extension Results PR Newswire
24.04.24 - PR Newswire
Calliditas Announces Positive NefIgArd Open Label Extension Results
Calliditas Announces Positive NefIgArd Open Label Extension Results PR Newswire
18.04.24 - PR Newswire
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024 PR ...
18.04.24 - PR Newswire
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024 PR ...
09.04.24 - PR Newswire
Calliditas Therapeutics to Attend Conferences in April
Calliditas Therapeutics to Attend Conferences in April PR Newswire
09.04.24 - PR Newswire
Calliditas Therapeutics to Attend Conferences in April
Calliditas Therapeutics to Attend Conferences in April PR Newswire
08.04.24 - PR Newswire
Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires
Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires PR Newswire
08.04.24 - PR Newswire
Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires
Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires PR Newswire
08.04.24 - PR Newswire
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment PR Newswire
08.04.24 - PR Newswire
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment PR Newswire
11.03.24 - PR Newswire
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon®
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-​Year Orphan Drug Exclusivity Period for Nefecon® PR Newswire
06.03.24 - PR Newswire
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO® PR Newswire
06.03.24 - PR Newswire
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO®
Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO® PR Newswire
01.03.24 - PR Newswire
Calliditas Therapeutics to Attend Investor Conferences in March
Calliditas Therapeutics to Attend Investor Conferences in March PR Newswire
01.03.24 - PR Newswire
Calliditas Therapeutics to Attend Investor Conferences in March
Calliditas Therapeutics to Attend Investor Conferences in March PR Newswire
21.02.24 - PR Newswire
Calliditas Year-end report, January - December 2023
Calliditas Year-end report, January - December 2023 PR Newswire
21.02.24 - PR Newswire
Calliditas Year-end report, January - December 2023
Calliditas Year-end report, January - December 2023 PR Newswire
14.02.24 - PR Newswire
Invitation to the presentation of Calliditas´ Year-end report January - December 2023
Invitation to the presentation of Calliditas´ Year-end report January - December 2023 PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »